NFE2L2 and neoplasm: The potentially adverse effects of NRF2 activation in pre-neoplastic lesions and in tumour cells are well recognised and have been referred to by Donna Zhang’s laboratory as the ‘dark side’ of the transcription factor [165,166,167,276].